This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox (CLX) Up 2.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Can Soap & Cleaning Materials Industry Players Balance Costs & Growth?
by Zacks Equity Research
The FMCG space continues its struggles against higher raw material and transportation costs. Meanwhile, product innovation, marketing initiatives and restructuring actions should aid growth.
UN vs. CLX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UN vs. CLX: Which Stock Is the Better Value Option?
Company News For Feb 5, 2019
by Zacks Equity Research
Companies In The News Are: PZZA,ULTI,CLX,SYY
Clorox (CLX) Jumps: Stock Rises 5.7%
by Zacks Equity Research
Clorox (CLX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Google Earnings Preview & Today's Trending Tickers: PZZA, TSLA, CLX
by Ryan McQueeney
Ryan McQueeney discusses news involving Papa John's, Tesla, Clorox, and Sysco. Later, he previews Alphabet's upcoming earnings announcement and explains what investors should watch for in the internet giant's report.
Economic & Earnings Data Deluge
by Zacks Equity Research
Economic & Earnings Data Deluge
Q4 Earnings Soldier on Gamely: GOOGL, CLX & More
by Mark Vickery
Eearnings reports to this point, based on strong consumer confidence and historically robust employment data (see Friday's 300K+ new jobs created last month), have been surprisingly positive amid these various and unpredictable headwinds.
Clorox (CLX) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Clorox (CLX) retains forecasts for fiscal 2019, which should benefit from ongoing cost-savings plans.
Clorox (CLX) Beats Q2 Earnings Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 6.06% and -0.40%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
UN vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
UN vs. CLX: Which Stock Is the Better Value Option?
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Clorox (CLX) Retain Earnings Beat Trend Despite All Odds?
by Zacks Equity Research
Clorox's (CLX) second-quarter fiscal 2019 results are poised to benefit from the ongoing 2020 Strategy, e-commerce enhancement and brand investments. However, margin woes may hurt results.
Can Clorox's Strategic Growth Efforts Offset Margin Issues?
by Zacks Equity Research
Clorox (CLX) witnesses strained margins due to higher costs. Nevertheless, its 2020 Strategy and Go Lean initiative to rebuild margins are encouraging.
UN or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CLX: Which Stock Is the Better Value Option?
Clorox's (CLX) 2020 Strategy on Track, Margin Woes Linger
by Zacks Equity Research
Clorox (CLX) benefits from 2020 strategy, expansion of e-commerce capabilities and brand management initiatives. However, dismal margins and soft fiscal earnings view are concerns.
UL vs. CLX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Why Is Clorox (CLX) Up 8% Since Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Gains 35% in 6 Months: Will the Rally Continue?
by Zacks Equity Research
Clorox (CLX) benefits from its solid strategic efforts, including 2020 strategy, expansion of e-commerce capabilities and brand management initiatives.
Clorox (CLX) Earnings and Sales Surpass Estimates in Q1
by Zacks Equity Research
Clorox (CLX) posts solid first-quarter fiscal 2019 numbers. Further, management trimmed its earnings view for the fiscal year, while reaffirmed sales outlook.
Clorox (CLX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 1.89% and 1.72%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
CLX, EL Q1 Earnings on Oct 31: Here are the Key Predictions
by Zacks Equity Research
Clorox (CLX) and Estee Lauder (EL) are slated to report first-quarter fiscal 2019 results on Oct 31.
Can Clorox (CLX) Retain its Earnings Beat Streak in Q1?
by Zacks Equity Research
Clorox (CLX) gains from its 2020 Strategy, Go Lean Strategy, enhancement of e-commerce business and disciplined capital allocation, which are likely to drive first-quarter fiscal 2019 results.
Clorox (CLX) Q1 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Clorox (CLX) Could Beat Earnings Estimates Again
by Zacks Equity Research
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.